This effort encompasses the detection, identification, growth, purification, analysis and detoxification of known and new biological pathogens to support the combat capabilities development command,…
Ended Awarded Last action
- Contract number
- W911SR22F0029
- Awardee
-
Excet, LLC UEI QZLMELMCJ2E3
- Awarding agency
-
ACC Aberdeen Proving Ground
Army Contracting Command, Department of Defense
- Obligated
- $152,999
Award facts
- Opportunity
-
- Chemical Biological Defense and Biomanufacturing Research Support Pre-Solicitation · W911SR21RBMRC · Posted Jan 25, 2021
- Contract value 38% obligated
-
- $155,337.28 Current, with exercised options
- $398,262.28 Potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- Contracting staff
- Funding agency
- Research Development and Engineering Command Army Materiel Command, Department of Defense
- NAICS code
- 541714 Research and Development in Biotechnology (except Nanobiotechnology)
- PSC
- AJ12 General Science And Technology R&D Services; General Science And Technology; Applied Research
- Set-aside
- No set-aside
- Competition
- Full and Open Competition after exclusion of sources Negotiated Proposal / Quote
- Pricing
- Cost Plus Fixed Fee
- Place of performance
- Springfield, VA 22150, USA
- Legislative mandates
-
- Service Contract Act FAR subpart 22.10
Award details come from SAM.gov/FPDS.
Transactions
| Action | Obligated | Date |
|---|---|---|
| Other Administrative Action | $0 | |
| Funding Only Action | $5,400 | |
| Funding Only Action | $30,311 | |
| Other Administrative Action | $0 | |
| Original award | $117,288 |
About this award
This is a federal contract award to Excet, LLC (doing business as Excet Inc.), a for-profit limited liability company based in Lexington Park, Maryland. The contract, valued at $398,262.28, was awarded by the U.S. Army's Research, Development and Engineering Command (RDECOM) to support the Combat Capabilities Development Command, Chemical Biological Center.
The contract encompasses the detection, identification, growth, purification, analysis, and detoxification of known and new biological pathogens. This work supports the development of combat capabilities related to chemical and biological defense. The contract is a Delivery Order with a Cost Plus Fixed Fee pricing type and has a period of performance through March 13, 2025. This award is not a set-aside contract. Excet, a versatile contractor with expertise in areas like chemical and biological defense, has secured numerous federal contracts across agencies including the Office of Naval Research and the Defense Advanced Research Projects Agency (DARPA).
Description
This effort encompasses the detection, identification, growth, purification, analysis and detoxification of known and new biological pathogens to support the combat capabilities development command, chemical biological center.
Quick answers
Who was awarded contract W911SR22F0029?
W911SR22F0029 was awarded to Excet, LLC by ACC Aberdeen Proving Ground (Army Contracting Command) on March 14, 2022.
How much is contract W911SR22F0029 worth?
The government has obligated $152,999 on W911SR22F0029. Its current value, with exercised options, is $155,337. Its potential value, with all options, is $398,262.
Which agency awarded contract W911SR22F0029?
ACC Aberdeen Proving Ground (Army Contracting Command) awarded W911SR22F0029, with funding from Research Development and Engineering Command (Army Materiel Command).
Is contract W911SR22F0029 an order under another contract?
Yes. W911SR22F0029 is a delivery order under W911SR22D0039, an indefinite delivery contract.
Was contract W911SR22F0029 competed?
The extent of competition for W911SR22F0029 was full and open competition after exclusion of sources.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award